3 year follow up of a randomised controlled trial of combination regimes of insulin, repaglinide and metformin in people with type 2 diabetes mellitus

被引:0
|
作者
Srinivasan, BT
Lawrence, IG
Tringham, J
Jarvis, J
Howe, J
Skinner, C
McNally, PG
Davies, MJ
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A127 / A127
页数:1
相关论文
共 50 条
  • [1] Insulin treatment after 3 years in patients with type 2 diabetes following participation in a study of combination regimes of insulin, repaglinide and metformin
    Lawrence, IG
    Srinivasan, BT
    Tringham, J
    Jarvis, J
    Howe, J
    Skinner, C
    McNally, PG
    Davies, MJ
    DIABETES, 2005, 54 : A513 - A513
  • [2] Rapid effect of repaglinide in combination with metformin in poorly controlled obese patients with type 2 diabetes mellitus
    Kurashvili, R.
    Asatiani, N.
    Nishnianidze, M.
    Dundua, M.
    Shelestova, E.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S163 - S163
  • [3] Repaglinide in combination therapy with metformin in Type 2 diabetes
    Moses, R
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S136 - S139
  • [4] Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
    Lundby-Christensen, Louise
    Tarnow, Lise
    Boesgaard, Trine W.
    Lund, Soren S.
    Wiinberg, Niels
    Perrild, Hans
    Krarup, Thure
    Snorgaard, Ole
    Gade-Rasmussen, Birthe
    Thorsteinsson, Birger
    Roder, Michael
    Mathiesen, Elisabeth R.
    Jensen, Tonny
    Vestergaard, Henrik
    Hedetoft, Christoffer
    Breum, Leif
    Duun, Elsebeth
    Sneppen, Simone B.
    Pedersen, Oluf
    Hemmingsen, Bianca
    Carstensen, Bendix
    Madsbad, Sten
    Gluud, Christian
    Wetterslev, Jorn
    Vaag, Allan
    Almdal, Thomas P.
    BMJ OPEN, 2016, 6 (02):
  • [5] Effects of metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus: the CIMT randomised clinical trial
    Lundby-Christensen, L.
    DIABETOLOGIA, 2013, 56 : S37 - S38
  • [6] Enhancement of early- and late-phase insulin secretion and insulin sensitivity by the combination of repaglinide and metformin in type 2 diabetes mellitus
    Rudovich, NN
    Dieken, MGL
    Rochlitz, H
    Pfeiffer, AFH
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2004, 112 (07) : 395 - 400
  • [7] Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin
    Moses, Robert G.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (03) : 331 - 342
  • [8] Comparison of metformin and insulin therapy for the treatment of gestational diabetes mellitus—a randomised controlled trial
    Papa Dasari
    Bhagyashree Gundagurti
    Kayathri Karthikeyan
    International Journal of Diabetes in Developing Countries, 2023, 43 : 523 - 528
  • [9] Fixed combination of repaglinide and metformin in the management of type 2 diabetes
    Moses, Robert
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 101 - 109
  • [10] Combination therapy in type 2 diabetes: Repaglinide/metformin vs glyburide/metformin
    Jinagouda, S
    Schwartz, S
    Huffman, D
    Weinstein, R
    Davidson, J
    Huang, WC
    Reinhardt, R
    DIABETES, 2001, 50 : A439 - A439